Technology
Boston Scientific has expanded its portfolio with COGNIS cardiac resynchronization therapy defibrillator (CRT-D) and TELIGEN implantable cardioverter defibrillator (ICD), new platforms to treat heart failure and sudden cardiac death.
May 13, 2008
News
May 13, 2008 - Boston Scientific reported that the FDA cleared its COGNIS cardiac resynchronization therapy ...
May 13, 2008Feature | Maureen Leahy-Patano
Many formerly invasive diagnostic and interventional cardiology procedures have migrated to less invasive or percutaneous options. The subsequent rise in cath lab procedures has increased the need for alternatives to manual compression that promote hemostasis at the access site, allowing for quicker patient ambulation and throughput.
May 13, 2008Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
May 14, 2008 - A randomized controlled trial conducted by Brigham and Women's Hospital in affiliation with Harvard ...
May 13, 2008Technology
The FDA cleared for marketing a new automated version of diaDexus’ proprietary PLAC Test, an automated immunoassay designed to run on common existing laboratory equipment, including clinical chemistry analyzers from Hitachi, Roche/Hitachi and Olympus, expanding the number of clinical labs and physician offices that are able to offer the PLAC Test.
May 12, 2008
Technology
TomTec Imaging Systems recently announced that its new CardioArena, the network and imaging solution for cardiology ...
May 12, 2008Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
May 13, 2008 - Edwards Lifesciences Corp. launched a next-generation transfemoral delivery system for the Edwards SAPIEN ...
May 12, 2008
Technology
Northeast Monitoring received clearance from the FDA to sell its DR200 Series devices with its automatic atrial ...
May 12, 2008Technology
Boston Scientific Corp. said the FDA approved three products in its Cardiac Rhythm Management business, including the ...
May 12, 2008Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
May 13, 2008 – The FDA cleared GE Healthcare’s new LightSpeed CT750 HD, said to be the world’s first high-definition CT ...
May 12, 2008
Technology
Boston Scientific’s IQ Guidewire is designed to provide the torque response, side branch access support and device ...
May 12, 2008
Technology
The Promote RF CRT-D and Current RF ICD feature InvisiLink radiofrequency (RF) telemetry for reportedly secure, wireless communication between the implanted device and the programmer, have extended their reach with the new Durata lead.
May 12, 2008Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
May 13, 2008 - Medtronic received FDA premarket approval (PMA) for the first wave of cardiac rhythm disease management ...
May 12, 2008
Technology
Boston Scientific's ALTRUA family of pacemakers is the first Boston Scientific-branded pacemaker to treat bradycardia ...
May 12, 2008
Technology
Medtronic’s Endeavor Zotarolimus-Eluting Coronary Stent System is engineered for the treatment of coronary artery disease. Endeavor uses the Driver bare metal cobalt alloy stent platform and the drug zotarolimus along with the proprietary, biocompatible drug delivery polymer.
May 12, 2008© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now